Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $80,604.72 +0.75%
Ethereum $2,345.23 +1.22%
BNB $748.76 +0.72%
Optimism $0.11 +1.76%
Arbitrum $0.17 +0.68%
Solana $100.94 +0.36%
Polygon $0.22 +2.77%
Cosmos $1.61 -1.17%
Avalanche $8.87 -0.49%

Bitcoin $80,604.72 +0.75%
Ethereum $2,345.23 +1.22%
BNB $748.76 +0.72%
Optimism $0.11 +1.76%
Arbitrum $0.17 +0.68%
Solana $100.94 +0.36%
Polygon $0.22 +2.77%
Cosmos $1.61 -1.17%
Avalanche $8.87 -0.49%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B